Denied

No. 18-1289

Allergan, Inc., et al. v. Teva Pharmaceuticals USA, Inc., et al.

from the United States Court of Appeals for the Federal Circuit

See other cases from the Federal Circuit.

Docket Entries

DISTRIBUTED for Conference of 5/30/2019.

Waiver of right of respondent Teva Pharmaceuticals USA, Inc. to respond filed.

Waiver of right of respondents Mylan Pharmaceuticals Inc.; Mylan, Inc. to respond filed.

Waiver of right of respondent Akorn, Inc. to respond filed.

Petition for a writ of certiorari filed. (Response due May 10, 2019)

Parties

Allergan, Inc., et al., Petitioner, represented by Jonathan E. Singer

Akorn, Inc., Respondent, represented by Michael R. Dzwonczyk

Mylan Pharmaceuticals Inc.; Mylan, Inc., Respondent, represented by Douglas H Carsten

Teva Pharmaceuticals USA, Inc., Respondent, represented by John Christohper Rozendaal

 
Last updated: November 23, 2024